For decades, confirming Alzheimer’s disease required a spinal tap or a PET scan that few patients ever received. In 2025 the FDA cleared the first plasma p-tau217 blood test, and 2026 is the year it begins reshaping who gets diagnosed, when, and what they can do about it.
A landmark 2026 study in Nature Aging reveals that phosphoenolpyruvate (PEP), a glycolytic metabolite, acts as a natural brake on the cGAS-STING inflammatory pathway. As PEP levels decline with age, chronic inflammaging accelerates — and restoring PEP in animal models delays aging phenotypes and improves cognition.
A landmark Science study reveals that genes control over 50 percent of lifespan variation. Meanwhile, the PROACT trial uses polygenic risk scores to find hidden heart disease, and whole genome sequencing is entering routine clinical care. Precision medicine in 2026 is no longer a promise. It is arriving.
A closer look at Yamanaka factors, partial reprogramming, David Sinclair, Altos Labs, and the widening gap between real age-reversal science and the hype surrounding it.
Researchers at the University of Geneva used machine learning to map gut bacteria at the subspecies level and detect 90% of colorectal cancers from a simple stool sample. The test rivals colonoscopy and outperforms every non-invasive screening tool currently in use. Here is what the science means for the future of cancer screening.
Breathing at six breaths per minute activates the vagus nerve, raises heart rate variability, and shifts the autonomic nervous system toward recovery. A growing body of peer-reviewed research shows that slow, controlled breathing is one of the most accessible and evidence-backed interventions for stress, inflammation, and long-term cardiovascular health.
First-generation senolytics like dasatinib plus quercetin showed only subtle effects in human trials. A new generation of senolytic CAR-T cells borrows cancer immunotherapy and retrains it to hunt senescent cells. Here is what the 2026 research reveals about the next frontier of cellular longevity medicine.
A cluster of landmark studies is forcing scientists to ask a radical question: could the drugs that conquered obesity also slow the biological clock? The answer is more complicated, and more important, than the headlines suggest. For most of their clinical history, GLP-1 receptor agonists were diabetes drugs. Then they became weight loss blockbusters. Now,…
🧬 Epigenetic Age Reversed 3+ Years — A clinical trial of 5-nucleotide supplementation reversed DNA methylation age by over three years in adults aged 60 to 70.
🧠Protein FTL1 Linked to Memory Decline — A newly identified protein weakens neuronal connections in aging brains, pointing to a potential new therapeutic target for cognitive decline.
🤖 AI Drug Industry Enters Clinical Era — With 173+ AI-designed drugs in human trials and Eli Lilly's $2.75B Insilico deal, AI is now a defining force in pharmaceutical development.
🦠Gut Bacteria Directly Control Human Immune Cells — Helmholtz Munich scientists discover common gut microbes inject proteins into human cells to shape immune behavior, a mechanism linked to inflammatory disease.
😴 Sleep Consistency Matters More Than Duration — New research shows that regularity of sleep timing predicts physical and mental wellbeing better than total sleep hours in older adults.
A landmark 2021 Stanford study found that a diet rich in fermented foods increased gut microbiome diversity and lowered 19 inflammatory proteins, while a high fiber diet did not. Here is what the science shows, how it connects to the four fundamentals of nutrition, breath, sleep, and movement, and what you can do starting with your next meal.
Zach RobertsSign up for personalized wellness coaching and the Daily Discovery Newsletter.